» Articles » PMID: 26743080

Loss of PPARγ in Endothelial Cells Leads to Impaired Angiogenesis

Abstract

Tie2-promoter-mediated loss of peroxisome proliferator-activated receptor gamma (PPARγ, also known as PPARG) in mice leads to osteopetrosis and pulmonary arterial hypertension. Vascular disease is associated with loss of PPARγ in pulmonary microvascular endothelial cells (PMVEC); we evaluated the role of PPARγ in PMVEC functions, such as angiogenesis and migration. The role of PPARγ in angiogenesis was evaluated in Tie2CrePPARγ(flox/flox) and wild-type mice, and in mouse and human PMVECs. RNA sequencing and bioinformatic approaches were utilized to reveal angiogenesis-associated targets for PPARγ. Tie2CrePPARγ(flox/flox) mice showed an impaired angiogenic capacity. Analysis of endothelial progenitor-like cells using bone marrow transplantation combined with evaluation of isolated PMVECs revealed that loss of PPARγ attenuates the migration and angiogenic capacity of mature PMVECs. PPARγ-deficient human PMVECs showed a similar migration defect in culture. Bioinformatic and experimental analyses newly revealed E2F1 as a target of PPARγ in the regulation of PMVEC migration. Disruption of the PPARγ-E2F1 axis was associated with a dysregulated Wnt pathway related to the GSK3B interacting protein (GSKIP). In conclusion, PPARγ plays an important role in sustaining angiogenic potential in mature PMVECs through E2F1-mediated gene regulation.

Citing Articles

The Role of Endothelial L-PGDS in the Pro-Angiogenic and Anti-Inflammatory Effects of Low-Dose Alcohol Consumption.

Li J, Li C, Subedi U, Subedi P, Panchatcharam M, Sun H Cells. 2024; 13(23).

PMID: 39682755 PMC: 11640003. DOI: 10.3390/cells13232007.


Integrating network pharmacology, molecular docking and non-targeted serum metabolomics to illustrate pharmacodynamic ingredients and pharmacologic mechanism of Haizao Yuhu Decoction in treating hyperthyroidism.

Huang W, Liu X, Li X, Zhang R, Chen G, Mao X Front Endocrinol (Lausanne). 2024; 15:1438821.

PMID: 39387049 PMC: 11462413. DOI: 10.3389/fendo.2024.1438821.


Mitochondria as a primary determinant of angiogenic modality in pulmonary arterial hypertension.

Niihori M, James J, Varghese M, McClain N, Lawal O, Philip R J Exp Med. 2024; 221(11).

PMID: 39320470 PMC: 11452743. DOI: 10.1084/jem.20231568.


Bhlhe40 Regulates Proliferation and Angiogenesis in Mouse Embryoid Bodies under Hypoxia.

Acosta-Iborra B, Gil-Acero A, Sanz-Gomez M, Berrouayel Y, Puente-Santamaria L, Alieva M Int J Mol Sci. 2024; 25(14).

PMID: 39062912 PMC: 11277088. DOI: 10.3390/ijms25147669.


Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: From Bedside to Bench and Back Again.

Bahi M, Li C, Wang G, Korman B Int J Mol Sci. 2024; 25(9).

PMID: 38731946 PMC: 11084945. DOI: 10.3390/ijms25094728.


References
1.
Calkin A, Thomas M . PPAR Agonists and Cardiovascular Disease in Diabetes. PPAR Res. 2008; 2008:245410. PMC: 2233765. DOI: 10.1155/2008/245410. View

2.
Tang Y, Harrington A, Yang X, Friesel R, Liaw L . The contribution of the Tie2+ lineage to primitive and definitive hematopoietic cells. Genesis. 2010; 48(9):563-7. PMC: 2944906. DOI: 10.1002/dvg.20654. View

3.
Pillai S, Kovacs M, Chellappan S . Regulation of vascular endothelial growth factor receptors by Rb and E2F1: role of acetylation. Cancer Res. 2010; 70(12):4931-40. PMC: 2891185. DOI: 10.1158/0008-5472.CAN-10-0501. View

4.
Lamalice L, Le Boeuf F, Huot J . Endothelial cell migration during angiogenesis. Circ Res. 2007; 100(6):782-94. DOI: 10.1161/01.RES.0000259593.07661.1e. View

5.
Madeddu P, Emanueli C, Pelosi E, Salis M, Cerio A, Bonanno G . Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs. FASEB J. 2004; 18(14):1737-9. DOI: 10.1096/fj.04-2192fje. View